The importance of inhibition of adhesion molecules in allergic inflammation;Znaczenie hamowania cza̧steczek adhezyjnych w zapaleniu alergicznym

Polski Merkuriusz Lekarski

Volumn 14, Issue 84, 2003, Pages 500-504

  Chciałowski, Andrzej ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Adhesion molecules; Allergic inflammation; Anti adhesion therapy

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CELL ADHESION MOLECULE; CHEMOKINE; CROMOGLYCATE DISODIUM; CYTOKINE; GLUCOCORTICOID; MUCOLYTIC AGENT; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; THEOPHYLLINE;

ALLERGIC DISEASE; ARTICLE; CELL INFILTRATION; CELL SURFACE; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; INFLAMMATION; MEDIATOR RELEASE;

EID: 0038444617     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Ahmad M., Theofanidis P., Medfort R.W.: Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-α. J. Biol. Chem., 1998, 273, 4616-4621.
2. Adamek-Guzik T., Czerniawska-Musik G., Guzik T.: Astma oskrzelowa - przewlekła̧ choroba̧ zapalna̧. Pregla̧d Lekarski. 1996, 53, 1, 12-19.
3. Beck-Schimmer B. i wsp.: Expression of lung vascular and airway ICAM1 after exposure to bacterial lipopolisaccharide. Am. J. Respir. Cell. Mol. Biol., 1997, 17, 344-352.
4. Berends C. i wsp.: Inhibition of PAF-induced expession of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram. Eur. Respir. J., 1997, 10, 1000-1007.
5. Blease K., Seybold J., Adcock I.M.: Interleukin-4 and lipopolisaccharide sinergize to induce Vascular Cell Adhesion Molecule-1 expression in human lung microvasoular endothelial cells. Am. J. Respir. Cell. Mol. Biol., 1998, 16, 620-630.
6. Bloemen P.G. M., Buckley T.L., van den Tweel M.C.: LFA-1 and Mac-1 is crucial for the development of hyperreactivity in a murine model of non-allergic asthma. A. J. Respir. Crit. Care. Med., 1996, 153, 521-529.
7. Calderon E., Lockey R.F.: A possible role for adhesion molecules in asthma. J. Allergy. Clin. Immunol., 1992, 90, 5, 852-864.
8. Chciałowski A.: Leczenie przeciwadhezyjne w zapaleniu alergicznym. W: Postȩpy w leczeniu chorych na astmȩ oskrzelowa̧. (red. T. Płusa). Warszawa. Medpress. 1999, 120-127.
9. Chciałowski A. i wsp.: Czasteczki adhezyjne LFA-1 (CD11a), Mac-1 (CD11b), ICAM-1 (CD54) limfocytów T pochodza̧cych z płukania oskrzelowo-pȩcherzykowego i krwi u chorych na przewlekłe choroby układu oddechowego. Pol. Merk. Lek., 2000, 8, 43, 13-17.
10. 2-integrin family on eosinophilic cell line. Ann. Allergy. Astma. Immunol., 1998, 81, 5, 448-450.
11. Cockerill G.W. i wsp.: Regulation of Granulocyte-Macrophage Colony-Stymulatig Factor and E-selectin expression in endothelial cells by Cyclosporin A and the T-cell transcription factor /NFAT/. Blood, 1995, 86, 7, 2689-2698.
12. Cronstein B.N. i wsp.: A mechanism for the antyinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leucocyte adhesion to endothelial cell and expression of endothelial-leucocyte adhesion molecule-1 and intercellular adhesion molecule-1. Proc. Natt. Acad. Sci., 1992, 89, 9991-9995.
13. Fal A.M.: Cza̧steczki adhezyjne. W: Choroby alergiczne i astma. (red. J Małolepszy). Volumed, 1996, 123-134.
14. Frew A.J., St-Pierre J., Teran L.M.: Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways. J. Allergy. Clin. Immunol., 1996, 98, 133-143.
15. Gola̧b J.: Udział cza̧steczek adhezyjnych w kra̧żeniu leukcytów. Klinika, 1995, 3, 3-8.
16. Goła̧b J.: Kra̧żenie limfocytów oraz migracja innych leukocytów. W: Immunologia. (red. Jakubisiak M.). PWN. Warszawa. 1998. 153-168.
17. Gratziou C., Carroll M., Montefort S.: Inflammatory and T-cell profile of asthmatic airways 6 hours after local allergen provocation. Am. J. Respir. Crit Care. Med., 1996, 153, 515-520.
18. Hamacher J., Schaberg T.: Adhesion molecules in lung diseases. Lung., 1994, 172, 189-213.
19. Hoshino M., Nakamura Y.: The effect of inhaled cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. Eur. Respir. J., 1997, 10, 858-865.
20. Iwamoto J.: The role of adhesion molecules in selective eosinophil recruitment. Allergy Clin. Immunol. News., 1994, 6, 6, 170-175.
21. Jacobson K. i wsp.: Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in subjects with asthma. Ann. Alergy Asthma Immunol., 1999, 83, 327-333.
22. Jutel M.: Prezentacja antygenów limfocytom T. W: Choroby alergiczne i astma. (red. J. Małolepszy). Volumed, 1996, 19-27.
23. Kelly B.E.A. i wsp.: The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am. J. Respir. Crit. Care. Med., 1997, 156, 1421-1428.
24. Kosmos E.N. i wsp.: Theophyliine induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics. Eur. Respir. J., 1999, 13, 53-58.
25. Kroegel C. i wsp.: Pulmonary immune cells in health and disease: the eosinophil leucocyte (part II). Eur. Respir. J., 1994, 7, 743-760.
26. Kroegel C. i wsp.: Pulmonary immune cells in health and disease: the eosinophil leucocyte (part I). Eur. Respir. J., 1994, 7, 519-543.
27. Kuna P.: Udział cytokin w patomechaniżmie zapalenia alergicznego. W: Postȩpy w alergolegii II. (red. T. Płusa). Medpress, Warszawa. 1997, 13-25.
28. Lee J.I., Burckart G.J.: Nuclear factor κ B: important transcription factor and therapeutic target. J. Clin. Pharmacol., 1998, 38, 11, 981-993.
29. Louis R., Shute J., Biagi S.: Cell infiltration, ICAM-1 expression and eosinophil chemotactic activity in asthmatic sputum. Am J. Respir. Crit. Care. Med., 1997, 155, 446-472.
30. Majewska E.: Cza̧steczki adhezyjne w zapaleniu. W: Zapalenie, Patofizjologia i klinika. (red. Tchórzewski H.). Medpress, Warszawa. 1998, 126-144.
31. Matsuse T. i wsp.: ICAM-1 mediates lung leucocyte recruitment but not pulmonary fibrosis in murine model of bleomycin-induced lung injury. Eur. Respir. J., 1999, 13, 71-77.
32. Mencer-Jones M.A. i wsp.: Inhibition of neutrophil migration at the site if infection increases remote organ neutrophil sequestration and injury. Shock, 1997, 8, 3, 193-199.
33. Montefort S. Holgate S.T., Howarth P.H.: Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur. Respir. J., 1993, 6, 1044-1054.
34. Nicolls M.R. i wsp.: Anti - LFA-1 therapy induces long-term islet allograft acceptance in the absence of INF-γ or IL-4. J. Immunol., 2000, 164, 3627-3634.
35. 2-adrenoceptor agonist. J. Asthma, 1998, 35, 401-408.
36. Okada T. i wsp.: A mechanism for the anti-inflammatory effect of nedocromil, inhibition of both adhesion molecule expression on eosinophils and endothelial cells, and eosinophil chemotactic activities. Arerugi., 1999, 48, 12, 1322-3130.
37. 4 integrins in pulmonary inflammation. In: Adhesion molecules and the lung. (ed. P.A Ward, J.C. Fantone). Marcel Dekker, Inc. New York - Basel - Hong-Kong. 1996, 267-277.
38. Pahl A., Szelenyi I.: Asthma therapy in the new millenium. Inflamm. Res., 2002, 51, 6, 273-282.
39. Pa̧czek L.: Leczenie immunosupresyjne. Nowa Klinika, 1999, 6, 621-624.
40. Pa̧czek L., Gaciong Z.: Zastosowanie kliniczne nowych leków immunosupresyjnych. Klinika, 1995, 3, 43-55.
41. Płusa T.: Zapalenie w układzie oddechowym. W: Zapalenie, patofizjologia i klinika. (red. Tchórzewki H.) Medpress, Warszawa. 1998, 251-263.
42. Saiki I.: Cell adhesion molecules and cancer matastasis. Jpn. J. Pharmacol., 1997, 75, 3, 215-242.
43. Silvestri M. i wsp.: Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur. Respir. J., 2001, 18, 139-145.
44. Silvestri M. i wsp.: Bronchial and bronchoalveolar inflammation in single early and dual responders after allergen inhalation challenge. Lung, 1997, 175, 277-285.
45. Soilu-Hanninen M. i wsp.: Therapy with antybody against leucocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis. J. Neuroimmunol., 1997, 72, 1, 95-105.
46. Spoelstra F.M. i wsp.: Effect of theophylline on CD11b and L-selectin expression and density of eosinophils and neutrophils in vitro. Eur Respir. J., 1998, 12, 585-591.
47. Spoelstra F.M. i wsp.: Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression on human lung fibroblasts. Eur. Respir. J., 2000, 15, 68-74.
48. Spoelstra F.M. i wsp.: Interferon-γ and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblast. Eur. Respir. J., 1999, 14, 759-766.
49. Takizawa T. i wsp.: Effectss of a new antiallergic drugs VUF-K-8788 in infiltration of lung parenchyma by eosinophils in guinea pigs and eosinophil-adhesion to human umbilical vein endothelial cells (HUVEC). Biol. Pharm. Bull., 2001, 24, 10, 1127-1132.
50. 4 integrins in antigen induced changes in microvascular permeability associated with lung inflammation in sensitized brown norway rats. Am. J. Respir. Cell. Mol. Biol., 1997, 17, 757-766.
51. Tchórzeski H.: Regulacja odczynu zapalnego. W: Zapalenie, Patofizjologia i Klinika. (red. Tchórzewski H.). Medpress, Warszawa. 1998, 13-37.
52. Wegner C.D.: Adhesion molecules in allergy. In: Progress in allergy and clinical immunology. (ed. S.G.O.Johansson). Hegrafe & Huber Publisher, Seatle - Toronto - Bern - Göttingen. 1995, 13-18.
53. Westermann J, Engelhardt B., Hoffmann J.C.: Migration of T cells in vivo: molecular mechanisms and clinical implications. Ann. Intern. Med., 2001, 135, 4, 279-295.